In patients with CAPS, myeloid-lineage restricted mutations in NLRP3 and somatic mosaicism6 allow NLRP3 activation in the absence of an activation signal, and priming alone is sufficient to trigger NLRP3 inflammasome-mediated IL-1β release33. The gene discussed is IL1B; the disease is cryopyrin-associated periodic syndrome.